Health Care/Hospital
QBiotics receives first registration for tigilanol tiglate with European Medicines Agency approval of Stelfonta(R)
* STELFONTA® (tigilanol tiglate) approved by the European Medicines Agency (EMA), making it the first pharmaceutical treatment available for all grades of canine non-metastatic mast cell tumours (MCT)[1] * The approval marks the first registration of QBiotic's, lead compound tigilanol tiglate...
2020-01-20 07:00
3416
111 Unveils New Video on The Impact of Chinese Policies to Medical Industry
SHANGHAI, Jan. 19, 2020 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, announced the release of the sixth episode in its 111 Insight series. The title announced today,The Impact of Chinese Policies to Medical Industry,...
2020-01-19 18:00
18388
Happiness Biotech Group Limited Announces Financial Results for the Six Months Ended September 30, 2019
NANPING, China, Jan. 17, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, today announced its unaudited financial results for the six months endedSeptember 30, 2019. The financial results...
2020-01-17 21:00
19159
111, Inc. Featured at 38th Annual JP Morgan Healthcare Conference
SHANGHAI, Jan. 17, 2020 /PRNewswire/ -- Junling Liu, co-founder, Chairman, and Chief Executive Officer of 111, Inc. (NASDAQ: YI) a leading integrated online and offline healthcare platform, gave an address entitled "Driving Transformation inChina's Healthcare and Pharmaceutical Industry" at the 3...
2020-01-17 20:00
7575
Snap Fitness Poised for Continued International Expansion in 2020
Fitness brand builds upon strong growth in 2019, with 50+ New Locations Opened CHANHASSEN, Minnesota, Jan. 16, 2020 /PRNewswire/ -- New clubs, new territories and new milestones are on the horizon for Snap Fitness. With more than one million members and 2,000+ clubs open or scheduled for developm...
2020-01-16 22:15
2797
LimaCorporate Inaugurates the New Research & Innovation Center for 3D Printing and the Advanced Laboratory for Testing and Analysis (ATLAs)
UDINE, Italy, Jan. 16, 2020 /PRNewswire/ -- LimaCorporate announces the official opening of new spaces entirely dedicated to 3D Printing and advanced testing: the Research & Innovation Center (R&I Center) and the Advanced Laboratory for Testing and Analysis (ATLAs). These new areas are located in...
2020-01-16 21:00
1879
China SXT Pharmaceuticals, Inc. Announced Regulatory Approval of Its DNA Exam Laboratory
TAIZHOU, China, Jan. 16, 2020 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Ad...
2020-01-16 21:00
6179
Transamerica Life Bermuda's Excellent Customer Service Recognised at the Benchmark Wealth Management Awards
HONG KONG, Jan. 16, 2020 /PRNewswire/ -- Transamerica Life (Bermuda) Ltd.
(TLB), a leading High Net Worth (HNW) life insurer, has won the "Outstanding
Achiever" award at the 10th Benchmark Wealth Management Awards in Hong Kong in
the category for "High Net Worth Client Servicing".
2020-01-16 16:21
4724
"Every Person Deserves the Chance to Live a Healthy and Productive Life" -- 2020 BUTTON Healthcare Cross-Border Partnering Summit -- From Globe to Asia
HEFEI, China, Jan. 16, 2020 /PRNewswire/ -- On the morning of January 13, 2020 (Pacific Time), the 38th J.P. Morgan Healthcare Conference opened in San Francisco as scheduled. At the same time, the "BUTTON Healthcare Cross-Border Partnering Summit - From Globe toAsia" was grandly held at the Merc...
2020-01-16 16:11
1154
WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany
* First drug product facility in Europe to complement WuXi Biologics' existing commercial manufacturing capacities * WuXi Biologics will be the back-up manufacturer for Kovaltry™ of Bayer SHANGHAI and LEVERKUSEN, Germany, Jan. 15, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a ...
2020-01-16 10:39
17988
FDF China to be held in June to boost Chinese pharmaceutical enterprises to "go global" and promote the innovation and development of industry
SHANGHAI, Jan. 16, 2020 /PRNewswire/ -- FDF China, collocated with CPhI China, will be held fromJune 22-24, 2020 at Shanghai New International Expo Centre (SNIEC). More and more formulation enterprises need to implement strategic layout to step up cooperation in innovation and facilitate the inte...
2020-01-16 09:52
2200
Hanmi Pharmaceutical participated in the 38th J.P. Morgan Healthcare Conference, announces that it is "ready to lead global pharmaceutical market with innovative R&D pipeline"
SEOUL, South Korea, Jan. 15, 2020 /PRNewswire/ -- The company, led by President and CEO Se-chang Kwon and co-representative Jong-soo Woo, participated in the 38th J.P. Morgan Healthcare Conference inSan Francisco during Jan. 13-15, which it presented its vision and major R&D strategies for 2020. ...
2020-01-16 07:30
1554
Prudential chooses IMG to boost travel assistance offerings and introduce new product
INDIANAPOLIS, Jan. 16, 2020 /PRNewswire/ -- International Medical Group® (IMG®), an award-winning global insurance benefits and assistance services company, has been chosen by The Prudential Insurance Company of America (Prudential) to provide increased travel assistance offerings and a new insu...
2020-01-16 01:30
18005
GenScript and Genopis Enter Into Strategic Partnership Agreement for Manufacture Service of GMP Plasmids
NANJING, China, Jan. 15, 2020 /PRNewswire/ -- On January 14, 2020, at San Francisco, USA, a global leading biotech company GenScript announced that it signed a strategic partnership agreement for the manufacturing service of GMP Plasmids with Genopis, Inc., a company that specializes in plasmid D...
2020-01-16 01:00
2078
Call for Application for 2020 Tsinghua Amgen Scholars Program
BEIJING, Jan. 15, 2020 /PRNewswire/ -- The Amgen Scholars Program (ASP) is an international program funded by the Amgen Foundation with the direction of Harvard University, aiming to increase research opportunities for students committed to pursuing careers in the field of biomedical science. Thro...
2020-01-15 18:18
2425
AXA Hong Kong launches the first 'AXA Chronic Disease Management Programme'
HONG KONG, Jan. 15, 2020 /PRNewswire/ -- According to a recent survey conducted by AXA Hong Kong, comprising 1,000Hong Kong people, it is deduced that more than one-third of those surveyed have been diagnosed with chronic diseases in which this proportion increased to over 50% in the 45-60 age gr...
2020-01-15 15:41
3570
Europ Assistance opens new office in Thailand
BANGKOK, Jan. 15, 2020 /PRNewswire/ -- Europ Assistance today announced the opening of their new office inBangkok, Thailand to provide its world-renowned travel and medical networks to the region and complete the presence of the Generali Group inThailand. This is part of their overall plan to acc...
2020-01-15 09:00
2085
Medit Responds to Ongoing Patent Infringement Lawsuit in Germany
SEOUL, South Korea, Jan. 14, 2020 /PRNewswire/ -- Medit today announced that there is an ongoing lawsuit inGermany in relation to European Patent no. 2 568 870 B1. The Regional Court of Duesseldorf in Germany rendered a judgment on January 9, 2020 (docket number 4c O 11/19), holding that Medit's...
2020-01-14 23:26
1743
ZAP Surgical Brain Tumor Treatments Commence at PLA General Hospital 301 in Beijing, China
SAN CARLOS, California, Jan. 14, 2020 /PRNewswire/ -- ZAP Surgical Systems, Inc. today announced that its ZAP-X® Gyroscopic Radiosurgery™ platform began clinical stereotactic radiosurgery (SRS) treatments at PLA General Hospital 301 (PLAGH 301) inBeijing, China. PLAGH 301 is the largest hospital ...
2020-01-14 23:07
2642
Innovent Out-Licenses Commercial Rights for Avastin® Biosimilar to Coherus BioSciences in the United States and Canada
SUZHOU, China, Jan. 14, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or the "Company") (HKEX: 01801), a biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today announced tha...
2020-01-14 08:00
16635
Week's Top Stories
Most Reposted
Mayapada Hospitality Holding Open the first voco Hotel in Indonesia.
[Picked up by 309 media titles]
2024-12-20 16:25
AI and Cyber Security Dominate ASEAN Enterprises' Digital Transformation Priorities
[Picked up by 306 media titles]
2024-12-20 18:11
XTransfer and OCBC Jointly Announce Comprehensive Partnership
[Picked up by 265 media titles]
2024-12-23 17:36
CKGSB Successfully Hosts 2024 MBA Professor Training Program for Western China
[Picked up by 251 media titles]
2024-12-24 00:06ebm-papst A&NZ Achieves Complete Operational Carbon Neutrality in appropriate Scope 1,2 and 3 criterion in 2023
[Picked up by 242 media titles]
2024-12-25 15:45Most Read
AI and Cyber Security Dominate ASEAN Enterprises' Digital Transformation Priorities
2024-12-20 18:11
11303
Mayapada Hospitality Holding Open the first voco Hotel in Indonesia.
2024-12-20 16:25
6317